Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2013 Mar;145(3):702–708. doi: 10.1016/j.jtcvs.2012.12.023

Table 3.

Association between Lymph Node micrometastatic status and normalized VEGF RT-PCR quantification cycles (Cq levels) in LNs

Normalized Variable Statistic Lymph Node micrometastatic status

Negative Positive Overall P-value

VEGF-A Mean (SD) /N 3.4 (1.7) /148 −0.7 (4.1) /41 2.5 (2.9) /189 <.0001
Median (Range) 3.5 (−2.7,6.5) 0.8 (−14.1, 3.7) 2.9 (−14.1,6.5)

VEGF-C Mean (SD)/N 5.1 (1.7)/148 2.3 (3.6) / 41 4.5 (2.5) /189 <.0001
Median (Range) 5.3 (−0.5, 8.3) 3.7 (−6.9,6.5) 5 (−6.9,8.3)

VEGF-D Mean (SD)/N 10.6 (1.8) /148 6.7(4.1)/41 9.7 (3) /189 <.0001
Median (Range) 10.9 (5.9, 14.3) 7.6 (−1.5, 13.2) 10.5 (−1.5, 14.3)

VEGF-Receptor 3 Mean (SD)/N 6.7 (1.5)/148 5.2 (2.8) / 41 6.4 (2) / 189 <.0025
Median (Range) 6.8 (2.1,9.8) 6.1 (−1.1, 10.3) 6.6 (−1.1, 10.3)

VEGF = Vascular Endothelial Growth Factor; SD = Standard Deviation; N = Sample Number

Note: Lower Cq values reflect higher mRNA expression levels